Clinical Trials Directory

Trials / Completed

CompletedNCT00576394

Aggressive Versus Moderate Glycemic Control in Diabetic Coronary Bypass Patients

Impact of Aggressive Versus Moderate Glycemic Control on Clinical Outcomes Following Coronary Artery Bypass Graft Surgery in Diabetic Patients

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
108 (actual)
Sponsor
American Heart Association · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

entGlycemic control has been found to improve clinical outcomes following Coronary Bypass Surgery. This study tests the hypothesis that obtaining tighter glycemic control(80-120mg/dl) as opposed to more moderate control (120-180mg/dl) will further improve outcomes.

Detailed description

150 diabetic patients will be randomized to achieve aggressive glycemic control (80-120mg/dl) vs moderate control (120-180mg/dl) using intravenous insulin infusions beginning at anesthetic induction and continuing for 18 hours following surgery.

Conditions

Interventions

TypeNameDescription
DRUGIV Insulin dripIV insulin drip at 100units insulin in 100ml saline designed to keep blood glucose between 120-180mg/dl
DRUGInsulinIV insulin drip to keep serum glucose between 80-120mg/dl.

Timeline

Start date
2006-10-01
Primary completion
2015-06-01
Completion
2015-06-01
First posted
2007-12-19
Last updated
2015-06-23

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00576394. Inclusion in this directory is not an endorsement.